Evidence map›Paper›PMID 22033038›Full record

ArticleCellular signalling2012

TGFβ and BMP-2 regulate epicardial cell invasion via TGFβR3 activation of the Par6/Smurf1/RhoA pathway.

Nora S Sánchez, Joey V Barnett

Abstract read
In one paragraph

Article in Cellular signalling, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Epicardium-myocardium crosstalk orchestrates heart development.Frontiers in cell and developmental biology · 2025
    Review
  3. The molecular mechanisms of cardiac development and related diseases.Signal transduction and targeted therapy · 2024
    Review
  4. Article
  5. CCBE1 Is Essential for Epicardial Function during Myocardium Development.International journal of molecular sciences · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Mesothelium and Malignant Mesothelioma.Journal of developmental biology · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Nora S SánchezDepartment of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232 USA. Electronic address: nora.s.sanchez@vanderbilt.edu.
Joey V BarnettDepartment of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232 USA. Electronic address: joey.barnett@vanderbilt.edu.
Genomic (Brazil) · BRVanderbilt University · US

Funding

TRAINING IN PHARMACOLOGICAL SCIENCEST32GM007628 · NIGMS · VANDERBILT UNIVERSITY · PI BARNETT, JOEY VICTOR, KAVALALI, EGE T · 1985 to 2022
$11.2M
Type III Transforming Growth Factor beta Receptor in Coronary Vessel DevelopmentR01HL085708 · NHLBI · VANDERBILT UNIVERSITY · PI BARNETT, JOEY VICTOR · 2008 to 2011
$1.7M
NHLBI NIH HHS HL085708NHLBI NIH HHS R01 HL085708NIGMS NIH HHS GM007628NIGMS NIH HHS T32 GM007628
6 · The paper itself

Abstract

Coronary vessel development requires transfer of mesothelial cells to the heart surface to form the epicardium where some cells subsequently undergo epithelial-mesenchymal transformation (EMT) and invade the subepicardial matrix. Tgfbr3(-/-) mice die due to failed coronary vessel formation associated with decreased epicardial cell invasion but the mediators downstream of TGFβR3 are not well described. TGFβR3-dependent endocardial EMT stimulated by either TGFβ2 or BMP-2 requires activation of the Par6/Smurf1/RhoA 1pathway where Activin Receptor Like Kinase (ALK5) signals Par6 to act downstream of TGFβ to recruit Smurf1 to target RhoA for degradation to regulate apical-basal polarity and tight junction dissolution. Here we asked if this pathway was operant in epicardial cells and if TGFβR3 was required to access this pathway. Targeting of ALK5 in Tgfbr3(+/+) cells inhibited loss of epithelial character and invasion. Overexpression of wild-type (wt) Par6, but not dominant negative (dn) Par6, induced EMT and invasion while targeting Par6 by siRNA inhibited EMT and invasion. Overexpression of Smurf1 and dnRhoA induced loss of epithelial character and invasion. Targeting of Smurf1 by siRNA or overexpression of constitutively active (ca) RhoA inhibited EMT and invasion. In Tgfbr3(-/-) epicardial cells which have a decreased ability to invade collagen gels in response to TGFβ2, overexpression of wtPar6, Smurf1, or dnRhoA had a diminished ability to induce invasion. Overexpression of TGFβR3 in Tgfbr3(-/-) cells, followed by siRNA targeting of Par6 or Smurf1, diminished the ability of TGFβR3 to rescue invasion demonstrating that the Par6/Smurf1/RhoA pathway is activated downstream of TGFβR3 in epicardial cells.

Indexed as

Signal TransductionAdaptor Proteins, Signal TransducingAdenoviridaeAnimalsBone Morphogenetic Protein 2Cell CommunicationCell DifferentiationCell LineCell MovementCoronary VesselsEpithelial CellsEpithelial-Mesenchymal TransitionGene ExpressionMiceMice, KnockoutPericardiumAdaptor Proteins, Signal TransducingbetaglycanBone Morphogenetic Protein 2Par6 protein, mouseProteoglycansReceptors, Transforming Growth Factor betarhoA GTP-Binding ProteinRNA, Small InterferingSmurf1 protein, mouseTgfb2 protein, mouseTransforming Growth Factor beta2Ubiquitin-Protein Ligases

Identifiers

PMID22033038
PMCPMC3237859
OpenAlexW1971934808

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.